Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oesophagogastric Cancer”

219 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 219 results

Testing effectiveness (Phase 2)UnknownNCT02177552
What this trial is testing

Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma

Who this might be right for
Esophageal NeoplasmsStomach Neoplasms
Rigshospitalet, Denmark 98
Not applicableStudy completedNCT03429816
What this trial is testing

OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric Carcinoma

Who this might be right for
Gastric NeoplasmGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma+2 more
University Hospital Heidelberg 120
Not applicableLooking for participantsNCT04443478
What this trial is testing

Laparoscopic Versus Open Lower Mediastinal Lymphadenectomy for Esophagogastric Junction Cancer

Who this might be right for
Gastric Cancer
Peking University 1,036
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06469060
What this trial is testing

Neoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric Junction

Who this might be right for
Esophageal Cancer
Shanghai Chest Hospital 34
Not applicableLooking for participantsNCT06158919
What this trial is testing

PD-1 Inhibitors Combined With Fruquintinib and Chemotherapy in First-line Treatment of HER2-negative Advanced G/GEJ Cancer

Who this might be right for
Gastric Cancer/Adenocarcinoma of Esophagogastric Junction
Fudan University 58
Testing effectiveness (Phase 2)Looking for participantsNCT06461910
What this trial is testing

Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric CancerEsophagogastric Junction Adenocarcinoma
Zekuan Xu 30
Early research (Phase 1)Looking for participantsNCT06783569
What this trial is testing

A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsGastric CancerEsophagogastric Juction Cancer+1 more
JiaRay Group 94
Testing effectiveness (Phase 2)Study completedNCT03549494
What this trial is testing

Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction

Who this might be right for
Stomach NeoplasmGastrointestinal NeoplasmsDigestive System Neoplasm+7 more
Catalysis SL 45
Testing effectiveness (Phase 2)Study completedNCT00737373
What this trial is testing

Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus Cancer

Who this might be right for
Gastric CancerAdenocarcinoma of the Esophagogastric Junction
Krankenhaus Nordwest 143
Not applicableLooking for participantsNCT07142122
What this trial is testing

Safety Comparison of Total Laparoscopic Proximal Gastrectomy With or Without Preservation of the Celiac Branch of the Vagus Nerve for Early Upper Gastric Cancer: A Randomized Controlled Clinical Trial

Who this might be right for
Gastric Cancer
Fujian Cancer Hospital 76
Not applicableLooking for participantsNCT06668454
What this trial is testing

Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol)

Who this might be right for
Esophageal CancerGastric CancerOligometastatic Disease
University Health Network, Toronto 72
Large-scale testing (Phase 3)Ended earlyNCT01285557
What this trial is testing

Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial

Who this might be right for
Metastatic Diffuse Gastric Cancer Including Carcinoma of the Gastro-esophageal Junction
Taiho Oncology, Inc. 361
Large-scale testing (Phase 3)UnknownNCT01015339
What this trial is testing

Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

Who this might be right for
Advanced Gastric Cancer
Peking University 320
Not applicableLooking for participantsNCT06162767
What this trial is testing

Cancer of Esophagogastric Junction: Optimized Sweet Versus Ivor-Lewis

Who this might be right for
Esophagogastric Junction Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 240
Not applicableLooking for participantsNCT02988921
What this trial is testing

MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing Chemoradiotherapy

Who this might be right for
Esophagus CancerEsophagogastric Junction Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 300
Testing effectiveness (Phase 2)UnknownNCT04263870
What this trial is testing

Conversion Therapy With Sintilimab Plus CAPOX in Patients With Unresectable Locally Advanced or Limited Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

Who this might be right for
Gastroesophageal Junction AdenocarcinomaStomach AdenocarcinomaLocally Advanced Unresectable Gastric Adenocarcinoma+1 more
Sichuan University 36
Not applicableLooking for participantsNCT04455282
What this trial is testing

CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1

Who this might be right for
Cancer of EsophagusEsophagogastric Junction Disorder
Heinrich-Heine University, Duesseldorf 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05986227
What this trial is testing

The Sequential Combination of FOLFOX and Toripalimab for Perioperative Immuno-Oncology Therapy of HER2-negative Adenocarcinoma of the Esophagogastric Junction (Siewert I/II):

Who this might be right for
Gastroesophageal Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 126
Testing effectiveness (Phase 2)Active Not RecruitingNCT03443856
What this trial is testing

Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence

Who this might be right for
Gastric and Esophagogastric Junction Adenocarcinoma
European Organisation for Research and Treatment of Cancer - EORTC 197
Testing effectiveness (Phase 2)Study completedNCT02273713
What this trial is testing

The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION)

Who this might be right for
Esophageal CancerToxicity
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 154
Load More Results